Sign In
News Digest /
Lukas Schmidt
Author: Lukas Schmidt
02:37am, Monday, Nov 11, 2024
Vietnam mandates Shein and Temu to register by November or face domain blocks, stirring concern among traders. The e-commerce giants face increasing regulatory pressures amid rising local market tensions. Compliance will be key for their Southeast Asia strategies.
02:31am, Monday, Nov 11, 2024
SoftBank Group (TYO: 9984) is set to report a quarterly profit of about 287 billion yen ($1.87 billion), driven by successful IPOs, despite potential currency impacts. Analysts are eager for insights on future investments amid a strong balance sheet and AI ambitions.
02:25am, Monday, Nov 11, 2024
Continental (XETRA: CON) revised its 2024 sales forecast to €39.5-42 billion amid declining demand in Europe and North America. Despite this, it reported a Q3 core profit of €873 million, boosting shares by 3.5%. Investors should monitor future strategy adaptations.
05:02am, Friday, Nov 08, 2024
Sony (NYSE: SONY) shares surged after reporting a 73% increase in operating profit for Q2, driven by strong gains in gaming and network services. The company maintains its profit guidance and has raised its 2025 revenue forecast, suggesting robust growth ahead.
09:16am, Thursday, Nov 07, 2024
Baird analysts suggest JPMorgan Chase (NYSE: JPM) investors consider profit-taking after a strong year, warning of potential "over-earning." While robust performance continues, concerns about stock valuation and future earnings prompt caution among traders.
09:15am, Thursday, Nov 07, 2024
CRH Plc's stock surged after reporting a 12% EBITDA increase to $2.454 billion for Q3, despite industry challenges. Analysts predict 10% organic growth, bolstered by acquisitions. The firm remains shareholder-friendly with buybacks and steady dividends.
05:07am, Thursday, Nov 07, 2024
Qualcomm (NASDAQ: QCOM) surpassed earnings expectations with a Q4 adjusted EPS of $2.69 on $10.24 billion revenue, triggering a 7% rise in premarket trading. The company is optimistic about Q1 forecasts and announced a $15 billion stock buyback, despite mixed analyst views.
04:57am, Thursday, Nov 07, 2024
Lyft Inc (NASDAQ: LYFT) shares surged over 20% in premarket trading after a strong Q3 report, revealing $1.52 billion in revenue. Analysts maintain a Buy rating, boosting their price target from $16 to $19, highlighting Lyft's growing active riders and positive future outlook.
04:51am, Thursday, Nov 07, 2024
Wizz Air (LSE: WIZZ) faces significant challenges, reporting a larger-than-expected dip in first-half net profit amid engine inspections and Middle East tensions. Stocks dropped 3.1% despite steady demand. The airline remains focused on operational efficiency and core markets.
06:28am, Tuesday, Nov 05, 2024
BlackRock's $2.1 billion investment in Bitcoin via its iShares Bitcoin Trust marks record inflows, with $872 million on one day. Bitcoin, currently at $68,308, faces volatility ahead of the Fed's interest rate decision, which could influence market dynamics.
06:23am, Tuesday, Nov 05, 2024
PRA Group, Inc. (PRAA) reported a robust Q3 2024, showcasing a 30% revenue jump to $281M and net income of $27M ($0.69/share). With $1.4B in cash collections, ERC hit a record $7.3B. The company aims for $1B in portfolio purchases for 2024, despite rising legal costs.
06:19am, Tuesday, Nov 05, 2024
Clearwater Paper Corporation (NYSE: CLW) reported Q3 2024 adjusted EBITDA of $64M, affected by Hurricane Helene. Following its $1.06B tissue business sale, Clearwater pivots to paperboard packaging, targeting $1.8B in revenues and $50M in cost savings.
06:17am, Tuesday, Nov 05, 2024
The Hackett Group (NASDAQ: HCKT) reports strong Q3 2024 results with $79.8M in revenue and adjusted EPS of $0.43, exceeding expectations. A focus on GenAI and strategic acquisitions point to promising growth, alongside a new dividend of $0.11/share.
06:14am, Tuesday, Nov 05, 2024
EU regulators will decide by December 6 on Novo Holdings’ acquisition of Catalent. The deal, vital for expanding obesity drug production, faces scrutiny from both EU and U.S. bodies, potentially reshaping the competitive pharmaceutical landscape.
